E
EGBOT
Guest
LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis
Source: LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis
HTML:
LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, announced today that Enstilar has been approved by the U.S. Food and Drug Administration for the topical treatment of plaque psoriasis in adults 18 years of age and older.Source: LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis
